Priority Date: 04.09.12 (US 201261743398P)

PREVENTING PULMONARY RECURRENCE OF CANCER WITH LIPID-COMPLEXED CISPLATIN

  • Application ID: EP13836095
  • Status: GRANT OF PATENT INTENDED

Attorneys

operating since 1981
1151.71
Headquarter in London and 9 offices
active in Legal Services and IP Consulting
no operation time available
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). CMS Cameron McKenna Nabarro Olswang LLP is specialized in A61. Olswang, CMS Cameron McKenna Nabarro Olswang LLP is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 04.09.2012 - Priority Date (US 201261743398P)
  • 13.03.2014 - Publication A2 (WO2014039533)
  • 15.07.2015 - Publication A2 (EP2892524)

IPC Classification